Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AE58054 adjunctive to donepezil in mild to moderate Alzheimer's disease
2012-004764-22Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Alzheimer's disease (AD) comparing Lu AE58054 + donepezil with Placebo + donepezil (2 arms). Primary endpoint: Change in cognition (ADAS-Cog total score). Started Jan 2014; status: completed.
02
Drugs
Idalopirdine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2012-004764-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004764-22.